Microbiological Indicators of Patients Infected with SarsCov-2
DOI:
https://doi.org/10.62480/tjms.2023.vol21.pp41-45Keywords:
antibiotic resistance, COVID-19, pneumoniaAbstract
The article presents a bacteriological analysis of patients admitted to the Bukhara Regional Infectious Diseases Hospital from March 16, 2020 to February 02, 2022 with a diagnosis of coronavirus infection COVID-19 and confirmed infection with SARS-CoV-2 (positive RT-positive in real time) . PCR typical of SARS-CoV-2) Results are shown for stool samples taken from patients Pr. Vulgaris, pr. Mirobllis, Kl.phevmoniae, Enterobacter hafniae from sputum samples of St. Pneumoniae, Can. greenish; S.epidermis, S.aureus were isolated from a blood sample. Most of the isolated microorganisms were sensitive to levofloxacin, amikacin, ciprofloxacin and cefoperazone sulbactam
References
.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019
novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with
pneumonia in China, 2019. N Engl J Med 2020; 382:727–33.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with
a new coronavirus of probable bat origin. Nature 2020; 579:270–3.
WHO. Coronavirus disease 2019 (COVID-19)—situation report—51. 2020.
Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates
the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 202; 368 (6490):489–93.
Abdurashid Rahimovich Oblokulov, Zilola Zohirovna Husenova, Maksudjon Muzaffarovich
Ergashev. (2021). Procalcitonin as an Indicator of Antibacterial Therapy in Covid-19. Annals of the
Romanian Society for Cell Biology, Volume 25: Issue 3. 5220–5224.
Shohida Abdulloyevna Muxtorova. (2022). Clinical and laboratoriya features of acute respiratory
disease in frequently ill children // Web of scientist: International scientific research journal.-2022.-
P. 1026-1030
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.